Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
Sponsors and collaborators
Gynecologic Oncology Group
National Cancer Institute (NCI)
Click here and scroll down to view study contact and location info
Ritu Salani, MD, MBA
Arthur G. James Cancer Hospital & Richard J. Solove Research Institute
Next post in Cervical Cancer Clinical Trials
Want to view more content from Cancer Therapy Advisor?
Register now at no charge to access unlimited clinical news, full-length features, case studies, conference coverage, and more.
Want to read more?
Please login or register first to view this content.